ArticleThoracic cancer2018

DNA damage response signaling as a predictive biomarker and synergistic therapeutic target for anti-PD-1/PD-L1 immunotherapy in non-small cell lung cancer.

Zhongling Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.